BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3460164)

  • 1. Effect of omeprazole on gastric acid secretion in man.
    Olbe L; Lind T; Cederberg C; Ekenved G
    Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid inhibitory characteristics of omeprazole in man.
    Cederberg C; Ekenved G; Lind T; Olbe L
    Scand J Gastroenterol Suppl; 1985; 108():105-12. PubMed ID: 3858972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
    Wilson JA; Boyd EJ; Wormsley KG
    Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
    Lind T; Cederberg C; Ekenved G; Haglund U; Olbe L
    Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.
    Larsson H; Mattson H; Sundell G; Carlsson E
    Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.
    Sharma BK; Walt RP; Pounder RE; Gomes MD; Wood EC; Logan LH
    Gut; 1984 Sep; 25(9):957-64. PubMed ID: 6469081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omeprazole on gastric acid secretion and plasma gastrin in man.
    Olbe L; Cederberg C; Lind T; Olausson M
    Scand J Gastroenterol Suppl; 1989; 166():27-32; discussion 41-2. PubMed ID: 2690329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW; Forrest JA; Reid JL
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four hour intragastric acidity during treatment with oral omeprazole.
    Pounder RE; Sharma BK; Walt RP
    Scand J Gastroenterol Suppl; 1986; 118():108-17. PubMed ID: 3460165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
    Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
    Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects.
    Ohning GV; Walsh JH; Pisegna JR; Murthy A; Barth J; Kovacs TO
    Aliment Pharmacol Ther; 2003 May; 17(9):1109-14. PubMed ID: 12752347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810).
    Lew EA; Barbuti RC; Kovacs TO; Sytnic B; Humphries TJ; Walsh JH
    Aliment Pharmacol Ther; 1998 Jul; 12(7):667-72. PubMed ID: 9701531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
    Williams MP; Sercombe J; Hamilton MI; Pounder RE
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous omeprazole rapidly raises intragastric pH.
    Walt RP; Reynolds JR; Langman MJ; Smart HL; Kitchingman G; Somerville KW; Hawkey CJ
    Gut; 1985 Sep; 26(9):902-6. PubMed ID: 4029717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P; Seitz HK; Simon B; Dammann HG
    Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of omeprazole on gastric acid secretion and plasma gastrin.
    Olbe L; Cederberg C; Lind T; Olausson M
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
    De Graef J; Woussen-Colle MC
    Gastroenterology; 1986 Aug; 91(2):333-7. PubMed ID: 2873074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.